Gts Securities LLC Takeda Pharmaceutical CO LTD Transaction History

Gts Securities LLC

  • $45.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$12.6 - $13.67 $4.16 Million - $4.51 Million
-330,165 Reduced 89.61%
38,294 $495,000
Q1 2024

May 15, 2024
SELL
$13.89 - $15.04 $700,903 - $758,933
-50,461 Reduced 12.05%
368,459 $5.12 Million
Q4 2023

Feb 14, 2024
BUY
$13.36 - $15.43 $5.6 Million - $6.46 Million
418,920 New
418,920 $5.98 Million

Others Institutions Holding TAK

# of Institutions
337
Shares Held
73.8M
Call Options Held
1.96M
Put Options Held
165K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email